Participants
Deal Summary
Altesa announced a $75 million fundraising round to develop its oral respiratory medication. The capital will support further clinical development and commercialization efforts.
BioTech Deals and Investments
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Comments
Want to join the conversation?
Loading comments...